Armstrong’s Entire Cycling Career Fueled by Doping, USADA Says

Seven-time Tour de France winner Lance Armstrong’s entire cycling career was fueled by performance-enhancing drugs, the U.S. Anti-Doping Agency said in a summary of its case against him.

Armstrong also required teammates to use banned substances or he would dismiss them from his squad, the report says. He also paid Michele Ferrari, a physician who played a “major role” in his doping program, $1 million, the report says.

Armstrong, 41, won the Tour de France every year from 1999-2005 with the U.S. Postal Service and Discovery teams.

To contact the reporter on this story: Mason Levinson in New York at mlevinson@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.